StockData
InnovAge Holding Corp. logo

InnovAge Holding Corp. (INNV) stock

INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3064% above fair value
$9.40−0.10 (-1.05%)

Close on Nov 12, 2026Market cap $1.28BP/E –Yield –

InnovAge Holding Corp. grew revenue 15.9% to $989.71M over the twelve months to Jun 30, 2026. Free cash flow was $50.41M, up 89.5% from a year earlier. At the latest close the market valued the company at $1.28B.

Revenue
$989.71M
+15.9% vs. a year earlier
Operating income
$2.62M
TTM Q4 2026
Free cash flow
$50.41M
+89.5% vs. a year earlier
EPS, diluted
-$0.02
TTM Q4 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$1.28B
P/E ratio
–
Price to sales
1.30
Price to book
5.44
Dividend yield
–
Free cash flow yield
3.93%

Fundamentals

Revenue
$989.71M
Net income
-$2.54M
EPS, diluted
-$0.02
Free cash flow
$50.41M
Book value per share
$1.73
Diluted shares
136M

Trading

Next earnings
Feb 2, 2027 (estimated, during market hours)
Previous close
$9.50
Open
$9.52
Day's range
$9.30 – $9.57
Volume
310,119
Average volume (20 days)
603,982
Index membership
Russell 2000 (since Jun 2021)
Beta (5 years)
0.68
52-week range
$4.70 – $12.64
RSI (14 days)
53.7
Volatility (1 year)
69.6%
Relative volume
0.80×
WACC
8.2%

Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodINNVS&P 500DifferenceINNV per yearS&P 500 per year
1 month+2.7%-2.7%+5.4 pts
3 months-9.9%-1.7%−8.1 pts
Year to date+81.1%+11.9%+69.2 pts
1 year+65.2%+12.0%+53.2 pts
3 years+69.4%+78.2%−8.8 pts+19.2%+21.2%
5 years+7.6%+73.2%−65.7 pts+1.5%+11.6%

Eight years at a glance

Fiscal years 2019 to 2026, USD

Revenue

$989.71M+15.9% YoY

Gross profit

$227.76M+48.2% YoY

Operating income

$2.62M

Net income

-$2.54M

EPS, diluted

-$0.02

Free cash flow

$50.41M+89.5% YoY
Reported period

Press releases

Releases InnovAge filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About InnovAge

Services-Health Services

InnovAge Holding Corp. operates as a healthcare delivery platform providing comprehensive, capitated care through the Program of All-Inclusive Care for the Elderly (PACE). The company coordinates and delivers all-inclusive medical and ancillary services, including skilled and unskilled in-home care, center-based primary care, physical and speech therapies, dental and psychiatric services, meals, activities, and patient transportation. InnovAge manages its business under a single reportable segment, PACE. Its services target frail, high-cost, nursing home-eligible seniors who are predominantly dual-eligible for both Medicare and Medicaid benefits.

Company profile, executives and history

InnovAge stock: common questions

What is InnovAge's stock price?

INNV closed at $9.40 on Nov 12, 2026, down 1.05% on the day. Over the past 52 weeks it traded between $4.70 and $12.64.

What is InnovAge's market cap?

InnovAge was worth $1.28B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is INNV's P/E ratio?

InnovAge lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.02), so it has no meaningful P/E ratio.

How much revenue does InnovAge make?

InnovAge reported revenue of $989.71M for the twelve months to Jun 30, 2026, up 15.9% from a year earlier.

Does InnovAge pay a dividend?

No. InnovAge has not paid a cash dividend over the last twelve months.

When does InnovAge report earnings next?

InnovAge is expected to report Q2 FY2027 results on Feb 2, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has INNV stock performed over the past year?

Including dividends, INNV returned +65.2% over the past year, against +12.0% for the S&P 500.

Who are InnovAge's competitors?

Companies most similar to InnovAge by business, industry and size include PNTG, PIII, USPH, PRVA, LFST.

See a number that looks wrong?